XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment

Property, plant & equipment is recorded at cost less allowances for depreciation. Depreciation is calculated using the straight-line method over the estimated useful life of the asset as follows:

 

Classification

 

Estimated Useful Life

Buildings

 

Thirty years

Leasehold improvements

 

Shorter of the term of the lease or estimated useful life

Equipment

 

Three to twelve years

Furniture, fixtures and office equipment

 

Three to eight years

Computer hardware and software

 

Three to seven years or estimated useful life

Reconciliation of Basic and Diluted Shares Amounts

A reconciliation of basic and diluted weighted average share outstanding is as follows:

 

 

 

For the Years Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

 

 

(Amounts in thousands, except per share data)

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income

 

$

185,959

 

 

$

128,291

 

 

$

59,926

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

Charges associated with convertible debt instruments, net of tax

 

 

387

 

 

 

 

 

 

 

Numerator for diluted earnings per share - net income available to common stockholders after the effect of dilutive securities

 

$

186,346

 

 

$

128,291

 

 

$

59,926

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average shares used in computing net income per
   share - basic

 

 

55,460

 

 

 

55,015

 

 

 

52,554

 

Effect of dilutive shares:

 

 

 

 

 

 

 

 

 

Options and stock units

 

 

608

 

 

 

915

 

 

 

971

 

Convertible senior notes

 

 

1,360

 

 

 

1,253

 

 

 

367

 

Contingent consideration

 

 

11

 

 

 

 

 

 

 

Dilutive effect of unvested performance stock units

 

 

16

 

 

 

81

 

 

 

 

Dilutive potential common shares

 

 

1,995

 

 

 

2,249

 

 

 

1,338

 

Denominator for diluted earnings per share - adjusted weighted average shares used in computing net income per share - diluted

 

 

57,455

 

 

 

57,264

 

 

 

53,892

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

3.35

 

 

$

2.33

 

 

$

1.14

 

Diluted

 

$

3.24

 

 

$

2.24

 

 

$

1.11

 

 

 

 

 

 

 

 

 

 

 

For the years ended December 31, 2022, 2021 and 2020
Summary of Product Revenues by Product Line

The following table represents product revenues by product line:

 

 

 

For the Years Ended December 31,

 

 

 

2022

 

 

2021(1)

 

 

2020(2)

 

 

 

(Amounts in thousands)

 

Filtration products

 

$

495,930

 

 

$

403,505

 

 

$

174,851

 

Chromatography products(3)

 

 

131,680

 

 

 

91,037

 

 

 

70,677

 

Process analytics products

 

 

53,512

 

 

 

48,019

 

 

 

33,346

 

Proteins products(3)

 

 

114,320

 

 

 

123,707

 

 

 

83,317

 

Other

 

 

5,741

 

 

 

4,051

 

 

 

3,945

 

Total product revenue

 

$

801,183

 

 

$

670,319

 

 

$

366,136

 

 

 

 

 

 

 

 

 

 

 

 

(1)
2021 revenue for filtration products includes revenue related to Polymem from July 1, 2021, as well as BioFlex and NTM from December 16, 2021 through December 31, 2021. 2021 revenue for proteins products includes revenue related to Avitide from September 20, 2021 through December 31, 2021.
(2)
2020 revenue for filtration products includes revenue related to EMT from July 13, 2020, NMS from October 20, 2020, and ARTeSYN from December 3, 2020 through December 31, 2020.
(3)
Revised 2020 revenue in the table above reflects a shift in product revenue from chromatography products to proteins products of approximately $3 million. These changes are consistent with the current year presentation of product revenue.
Total Assets by Geographic Area

The following table represents the Company’s total assets by our country of domicile (the United States) and other countries where our major subsidiaries are domiciled for the periods presented:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Total assets by geographic locations:

 

 

 

 

 

 

North America

 

$

2,209,244

 

 

$

2,082,721

 

Europe

 

 

287,543

 

 

 

243,076

 

APAC

 

 

27,871

 

 

 

32,557

 

Total assets by geographic location

 

$

2,524,658

 

 

$

2,358,354

 

Long Lived Assets by Geographic Area

The following table represents the Company’s long-lived assets by our country of domicile (the United States) and other countries where our major subsidiaries are domiciled for the periods presented:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Long-lived assets by geographic locations:

 

 

 

 

 

 

North America

 

$

275,151

 

 

$

198,436

 

Europe

 

 

38,541

 

 

 

27,168

 

APAC

 

 

2,819

 

 

 

1,534

 

Total long-lived assets by geographic location

 

$

316,511

 

 

$

227,138

 

Total Revenue  
Percentage by Geographic Area or Significant Customers

The following table represents the Company’s total revenue by our country of domicile (the United States) and other countries where our major subsidiaries are domiciled for the periods presented (based on the location of the customer):

 

 

 

For the Years Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Revenue by customers' geographic locations:

 

 

 

 

 

 

 

 

 

North America

 

 

43

%

 

 

41

%

 

 

48

%

Europe

 

 

37

%

 

 

40

%

 

 

38

%

APAC/Other

 

 

20

%

 

 

19

%

 

 

14

%

Total revenue

 

 

100

%

 

 

100

%

 

 

100

%

 

 

Trade Accounts Receivable Member  
Percentage of Revenue from Significant Customers is as follows:

 

 

 

December 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Purolite (an Ecolab Inc. company)

 

 

13

%

 

N/A

 

Pfizer Inc.

 

N/A

 

 

 

14

%